Category : Search result: pharmaceutical oversight


B.C. police complaints up, serious harm cases down

Police complaints in British Columbia increased by 32% last year, while serious harm investigations dropped significantly. Learn about the changing landscape of police oversight in B.C.

J&J buys Halda Therapeutics for $3.05 billion

Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.

Regina Street Team Changes Spark Controversy

Two members leave Regina's Downtown Street Team as oversight shifts from RDBID to new city-chosen organization, creating community concerns about service continuity.

Interim PBO Jason Jacques seeks permanent position

Interim Parliamentary Budget Officer Jason Jacques confirms he will apply for the permanent role, bringing continuity to Canada's fiscal oversight. Learn about his qualifications and vision.

Barbados Launches US$200M Life Sciences Hub

Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.

Trump Calls Epstein Case 'Democrat Hoax'

President Trump claims Democrats promote 'Epstein Hoax' to deflect from policy failures as new documents raise questions about his connections. House to vote on full file release.

Epstein Emails: Called Trump 'Dangerous' in 2017

Newly released Jeffrey Epstein documents reveal he privately warned Larry Summers that Donald Trump was 'dangerous' and had 'not one decent cell in his body' after the 2016 election.

Epstein emails allege Trump knew of his activities

Newly released emails by Democrats show Jeffrey Epstein alleged Donald Trump was aware of his activities. The revelations intensify scrutiny of their past relationship. Read the full story.

Epstein Emails Suggest Trump Knew About Crimes

Newly released Jeffrey Epstein emails allege Donald Trump was aware of his crimes. The House Oversight Committee obtained the evidence via subpoena. Read the full report.

Pfizer wins $10B obesity drug takeover battle

Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.

Trump's Plan to Slash Obesity Drug Prices

Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.

Trump's Drug Price Plan Backfires, Helps Democrats

Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Ontario bypasses public hearings on education power bill

The Ford government is using a legislative maneuver to fast-track controversial education legislation without public hearings, including a bill that would significantly expand the education minister's authority over school boards.

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Budget 2025 Cuts Intelligence Watchdog Funds

Canada's 2025 federal budget reveals significant cuts to intelligence oversight agencies, raising concerns about transparency and accountability in national security operations.

Page 2 of 3